Edap Tms (NASDAQ:EDAP) Announces Earnings Results

Key Points

• EDAP TMS reported a quarterly earnings per share of ($0.17), slightly outperforming the consensus estimate of ($0.18).
• The company has a market cap of $59.08 million and is currently rated as a "Hold" by analysts, with an average price target of $8.50.
• EDAP TMS operates in the development and marketing of minimally invasive medical devices, specifically for urological diseases using High Intensity Focused Ultrasound (HIFU) technology.

Edap Tms (NASDAQ:EDAP - Get Free Report) released its quarterly earnings results on Thursday. The medical equipment provider reported ($0.17) earnings per share for the quarter, beating analysts' consensus estimates of ($0.18) by $0.01, Zacks reports. Edap Tms had a negative net margin of 33.49% and a negative return on equity of 56.85%. The company had revenue of $21.92 million for the quarter, compared to analyst estimates of $16.60 million.

Edap Tms Price Performance

NASDAQ:EDAP traded up $0.33 during mid-day trading on Tuesday, hitting $2.59. 338,932 shares of the stock traded hands, compared to its average volume of 87,480. The business's 50-day moving average price is $1.51 and its 200 day moving average price is $1.83. The company has a market cap of $96.84 million, a PE ratio of -4.25 and a beta of -0.21. Edap Tms has a 12-month low of $1.21 and a 12-month high of $3.77. The company has a quick ratio of 1.05, a current ratio of 1.51 and a debt-to-equity ratio of 0.04.

Analysts Set New Price Targets

A number of research analysts recently weighed in on EDAP shares. Wall Street Zen started coverage on shares of Edap Tms in a research report on Thursday, May 15th. They set a "hold" rating on the stock. Piper Sandler lowered shares of Edap Tms from an "overweight" rating to a "neutral" rating in a research report on Thursday, May 15th. One investment analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the company's stock. According to MarketBeat.com, the company has an average rating of "Hold" and a consensus target price of $8.50.

Edap Tms Company Profile

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.